
FDA Launches precisionFDA Web Portal
The agency has launched a new web platform to foster scientific innovation.
As part of the Obama Administration’s Precision Medicine Initiative, FDA has launched its
The platform provides reference genomes and allows users to share their results, track changes, obtain feedback, and compare their results to previously validated reference results. FDA hopes that the collaborations developed by the precisionFDA platform will improve the quality and accuracy of genomic tests.
“precisionFDA leverages our experience establishing openFDA, an online community that provides easy access to our public datasets. Since its launch in 2014, openFDA has already resulted in many novel ways to use, integrate, and analyze FDA safety information. We’re confident that employing such a collaborative approach to DNA data will yield important advances in our understanding of this fast-growing scientific field, information that will ultimately be used to develop new diagnostics, treatments and even cures for patients,” said Johanson and Kass-Hout, in the blog post.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.